Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes—just in case they’re material to our investing thesis.

What: Elizabeth Arden (Nasdaq: RDEN) shares rose as much as 11% after the beauty products company reported a generally bullish second-quarter this morning.

So what: Things are looking pretty, oh so pretty, for Elizabeth Arden, which trounced analyst EPS estimates by $0.16 in the second quarter -- $1.20 versus a $1.04 consensus estimate. Oddly, revenue fell just a hair short of expectations, at $405.6 million versus the consensus estimate of $408.1 million. The company cited strong international growth as the main driver for the great quarter, specifically highlighting a double-digit jump in fragrance sales. The company also issued fiscal 2011 revenue guidance, which fell in the middle of the current estimates, while elevating its full-year EPS expectation to a range of $1.40 to $1.50.

Now what: Today has been an all-around victory for beauty supply stocks. Estee Lauder (NYSE: EL) reported a 33% jump in profit while Sally Beauty Holdings (NYSE: SBH) noted a 13% jump in revenue, so Elizabeth Arden's figures shouldn't come as much of a surprise. The concern I have with Elizabeth Arden is that despite its new guidance, it's really hard to justify paying almost 20 times forward earnings for a company that's growing revenue at only 4%. The real wild card will be whether European consumers can continue to buoy the company's sales figures. From a macroeconomic perspective, Europe's economies seem very shaky at best, so more foundation may need to be applied here before Elizabeth Arden can cover up its apparent blemishes.

Interested in more info on Elizabeth Arden? Add it to your watchlist by clicking here.